WHAT IS THE TREATMENT DURABILITY AND SAFETY PROFILE OF RHEUMATOID ARTHRITIS PATIENTS TREATED WITH INFLIXIMAB PLUS METHOTREXATE AND/OR LEFLUNOMIDE? AN ANALYSIS FROM A REAL-WORLD REGISTRY

被引：0
|
作者：
Faraawi, R. [1 ]
Joshi, R.
Bensen, W. [1 ]
Choquette, D. [2 ]
Olszynski, W. [3 ]
Arendse, R. [3 ]
Sheriff, M. [4 ]
Rahman, P. [5 ]
Sampalis, J. [6 ]
Rampakakis, E. [6 ]
Tkaczyk, C. [7 ]
Nantel, F. [7 ]
机构：
[1] McMaster Univ, Hamilton, ON, Canada
[2] Univ Montreal, Inst Rhumatol Montreal, Montreal, PQ, Canada
[3] Univ Saskatchewan, Saskatoon, SK, Canada
[4] Nanaimo Reg Hosp, Nanaimo, BC, Canada
[5] Mem Univ Newfoundland, St John, NF, Canada
[6] JSS Med Res, Montreal, PQ, Canada
[7] Janssen, Toronto, ON, Canada
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2015年 / 74卷
关键词：
D O I：
10.1136/annrheumdis-2015-eular.2402
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0168
引用
收藏
页码：714 / 714
页数：1
相关论文
共 50 条
  • [1] What Is the Treatment Durability and Safety Profile of Rheumatoid Arthritis Patients Treated with Infliximab Plus Methotrexate and/or Leflunomide? an Analysis from a Real-World Registry
    Faraawi, Rafat
    Joshi, Raman
    Bensen, William G.
    Choquette, Denis
    Olsynzynski, Wojciech
    Arendse, Regan
    Sheriff, Maqbool
    Rahman, Proton
    Rampakakis, Emmanouil
    Psaradellis, Eliofotisti
    Nantel, Francois
    Lehman, Allen J.
    Otawa, Susan
    Tkaczyk, Cathy
    Osborne, Brendan
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [2] What Is the Treatment Durability and Safety Profile of Rheumatoid Arthritis Patients Treated with Infliximab Plus Methotrexate and/or Leflunomide? An Analysis from the Real-world Registry, BioTRAC
    Faraawi, Rafat
    Joshi, Ramen
    Bensen, William
    Choquette, Denis
    Olszynski, Wojciech
    Arendse, Regan
    Sheriff, Maqbool
    Rahman, Proton
    Sampalis, John
    Rampakakis, Emmanouil
    Nantel, Francois
    Lehman, Allen
    Otawa, Susan
    JOURNAL OF RHEUMATOLOGY, 2015, 42 (07) : 1330 - 1330
  • [3] CHARACTERISITCS OF PATIENTS RECEIVING LEFLUNOMIDE, METHOTREXATE OR LEFLUNOMIDE PLUS METHOTREXATE FOR THE TREATMENT OF RHEUMATOID ARTHRITIS IN A REAL-LIFE SETTING IN COLOMBIA
    Santos-Moreno, R.
    Villarreal Peralta, L.
    Jaimes, H.
    Jaimes, J.
    Buitrago-Garcia, D.
    Castro, C.
    VALUE IN HEALTH, 2017, 20 (09) : A941 - A941
  • [4] Combination treatment with infliximab and methotrexate or leflunomide in active rheumatoid arthritis. Safety and efficacy
    Athanassiou, P
    Kostoglou-Athanassiou, I
    Koutsogeorgopoulou, L
    Galanaki, C
    Kordalis, A
    Konstantopoulou, R
    Sarlanis, T
    Vezyroglou, G
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 464 - 464
  • [5] TREATMENT RESPONSE WITH ABATACEPT PLUS METHOTREXATE TREATMENT FOR RHEUMATOID ARTHRITIS: REAL-WORLD EVIDENCE FROM THE UK
    Choy, E.
    Henning, S.
    Brazil, M.
    Pollock, K.
    Groves, L.
    Sugrue, D.
    Houghton, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1299 - 1299
  • [6] Improvement in hemoglobin in patients with rheumatoid arthritis treated with infliximab plus methotrexate
    Doyle, M. K.
    Rahman, M. U.
    Han, C.
    Han, J.
    Giles, J. T.
    Bingham, C. O., III
    Bathon, J. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 168 - 168
  • [7] Safety and efficacy of the association of leflunomide-infliximab versus methotrexate-infliximab in patients with rheumatoid arthritis
    Ibañez, TC
    Tayel, MY
    Sanz, AH
    Criado, AB
    Martín-Mola, E
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 469 - 469
  • [8] Improvement in hemoglobin in patients with rheumatoid arthritis treated with infliximab plus methotrexate
    Doyle, M.
    Rahman, M.
    Han, C.
    Han, J.
    Giles, J. T.
    Bingham, C. O.
    Bathon, J. M.
    RHEUMATOLOGY, 2008, 47 : II39 - II40
  • [9] What is the Impact of Rheumatoid Factor Positivity on the Real-world Effectiveness of Infliximab Treatment in Rheumatoid Arthritis?
    Choquette, Denis
    Faraawi, Rafat
    Zummer, Michel
    Chow, Andrew
    Kelsall, John
    Rampakakis, Emmanouil
    Sampalis, John
    Otawa, Susan
    Lehman, Allen
    Shawl, May
    JOURNAL OF RHEUMATOLOGY, 2013, 40 (06) : 965 - 965
  • [10] Long-Term Effectiveness and Safety of Infliximab in Rheumatoid Arthritis Patients: Real-World Data from the Biologic Treatment Registry Across Canada (BioTRAC)
    Olszynski, Wojciech
    Rahman, Proton
    Chow, Andrew
    Arendse, Regan
    Choquette, Denis
    Jaroszynska, Anna
    Sholter, Dalton
    Dixit, Sanjay
    Baer, Philip
    Kelsall, John
    Rampakakis, Emmanouil
    Osborne, Brendan
    Asin-Milan, Odalis
    Lehman, Allen
    Nantel, Francois
    JOURNAL OF RHEUMATOLOGY, 2019, 46 (07) : 786 - 786
12345